Analysis

Ocugen enters a make-or-break stretch that will test both its science and its stock. The gene therapy developer, which has...

Mercedes-Benz shares tumbled to a new 52-week trough of €42.64 on Monday, extending a year-to-date slide that now stands at...

Microsoft shares clawed back nearly 6% on Friday to close at €327.90, pulling away from a 52-week low set just...

The Czechoslovak Group presents a study in contradictions. The defence contractor’s order book bulges at €17 billion, revenue hit €1.5...

The next two months will determine whether DroneShield’s operational firepower can finally break the grip of regulatory uncertainty. All eyes...

AMD closed Friday at €457.30, shedding 2.31% on the session. After a year-to-date gain of roughly 140% and a 272%...

IBM shares have clawed back nearly 10% over the past seven trading days, closing Friday at €237.80 and reclaiming the...

Broadcom has strengthened both its enterprise cloud and artificial intelligence credentials in recent weeks, yet the stock continues to slide....

Munich Re is executing a two-pronged strategy that looks as different as the markets it serves. On one side, it...

June 29 shapes up as a pivotal session for Antimony Resources. Two powerful forces hit the stock simultaneously: the expiry...